Location: New York, NY
CIK: 0001493215 · Show all filings
Period: Q2 2018 (← Previous) (Next →)
Filing Date: Aug 14, 2018
Total Value: $1.387B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| RCKT | Rocket Pharmaceuticals Inc | 14,969,744 | $289M | 20.9% | $16.31 | +16.0% | COM | 77313F106 |
| RGNX | Regenxbio Inc | 2,079,555 | $149M | 10.8% | $24.63 | +93.9% | COM | 75901B107 |
| PTCT | Ptc Therapeutics Inc | 4,073,690 | $137M | 9.9% | $13.46 | +131.6% | COM | 69366J200 |
| SRPT | Sarepta Therapeutics Inc | 978,551 | $129M | 9.3% | $74.88 | +25.9% | COM | 803607100 |
| ARWR | Arrowhead Pharmaceuticals In | 8,299,542 | $113M | 8.1% | $8.23 | +13.6% | COM | 04280A100 |
| — | Dicerna Pharmaceuticals Inc | 5,044,813 | $61.8M | 4.5% | $10.56 | — | COM | 253031108 |
| BMY | Bristol Myers Squibb Co | 903,672 | $50.01M | 3.6% | $43.52 | -6.6% | COM | 110122108 |
| LIVN | Livanova PLC | 431,000 | $43.02M | 3.1% | $88.96 | +2.0% | SHS | G5509L101 |
| — | La Jolla Pharmaceutical Co | 1,345,881 | $39.26M | 2.8% | $26.28 | — | COM PAR $.0001 2 | 503459604 |
| — | Achillion Pharmaceuticals In | 13,541,997 | $38.32M | 2.8% | $3.82 | — | COM | 00448Q201 |
| ABUS | Arbutus Biopharma Corp | 5,165,499 | $37.71M | 2.7% | $3.27 | +82.2% | COM | 03879J100 |
| ALNY | Alnylam Pharmaceuticals Inc | 352,200 | $34.69M | 2.5% | $82.31 | +20.5% | COM | 02043Q107 |
| MASI | Masimo Corp | 249,543 | $24.37M | 1.8% | $77.72 | +22.3% | COM | 574795100 |
| — | Solid Biosciences Inc | 675,771 | $22.75M | 1.6% | $6.82 | — | COM | 83422E105 |
| VCEL | Vericel Corp | 2,217,916 | $21.51M | 1.6% | $6.40 | +94.6% | COM | 92346J108 |
| — | Agenus Inc | 9,375,451 | $21.28M | 1.5% | $6.00 | — | COM NEW | 00847G705 |
| — | Qiagen NV | 529,385 | $19.14M | 1.4% | $36.16 | — | SHS NEW | N72482123 |
| QURE | Uniqure NV | 409,370 | $15.47M | 1.1% | $15.23 | +110.3% | SHS | N90064101 |
| — | Corium Intl Inc | 1,923,217 | $15.4M | 1.1% | $8.35 | — | COM | 21887L107 |
| ILMN | Illumina Inc | 49,658 | $13.87M | 1.0% | $254.40 | 0.0% | COM | 452327109 |
| — | Myokardia Inc | 261,395 | $12.98M | 0.9% | $42.84 | — | COM | 62857M105 |
| VRAYQ | Viewray Inc | 1,474,156 | $10.2M | 0.7% | $6.41 | +13.3% | COM | 92672L107 |
| — | Polarityte Inc | 426,670 | $10.04M | 0.7% | $23.54 | — | COM | 731094108 |
| CDNA | Caredx Inc | 764,532 | $9.358M | 0.7% | $7.58 | +51.3% | COM | 14167L103 |
| — | Bovie Medical Corp | 2,082,137 | $9.057M | 0.7% | $3.19 | — | COM | 10211F100 |
| — | Electrocore Inc | 505,000 | $8.338M | 0.6% | $16.51 | — | COM | 28531P103 |
| — | Nuvectra Corp | 383,030 | $7.864M | 0.6% | $13.02 | — | COM | 67075N108 |
| — | Viveve Med Inc | 2,861,023 | $7.782M | 0.6% | $4.34 | — | COM NEW | 92852W204 |
| — | Odonate Therapeutics Inc | 276,368 | $6.102M | 0.4% | $22.75 | — | COM | 676079106 |
| STIM | Neuronetics Inc | 190,000 | $5.056M | 0.4% | $27.20 | 0.0% | COM | 64131A105 |
| — | Homology Medicines Inc | 226,431 | $4.619M | 0.3% | $18.70 | — | COM | 438083107 |
| — | Novavax Inc | 2,644,346 | $3.543M | 0.3% | $2.10 | — | COM | 670002104 |
| — | Vivus Inc 4.5 05/01/2020 | 4,000,000 | $3.14M | 0.2% | $0.79 | — | NOTE 4.500% 5/0 | 928551AA8 |
| — | Proteostasis Therapeutics In | 1,077,408 | $3.006M | 0.2% | $5.83 | — | COM | 74373B109 |
| ARGX | Argenx Se | 25,559 | $2.118M | 0.2% | $21.81 | — | SPONSORED ADR | 04016X101 |
| — | Novus Therapeutics Inc | 301,799 | $2.113M | 0.2% | $5.04 | — | COM | 67011N105 |
| — | Tapimmune Inc | 200,000 | $1.886M | 0.1% | $9.43 | — | COM PAR | 876033408 |
| — | Bellicum Pharmaceuticals Inc | 150,289 | $1.109M | 0.1% | $7.38 | — | COM | 079481107 |
| — | Adverum Biotechnologies Inc | 176,372 | $935K | 0.1% | $5.80 | — | COM | 00773U108 |
| — | Motus Gi Hldgs Inc | 59,478 | $428K | 0.0% | $4.48 | — | COM | 62014P108 |